戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ol ester transfer protein, paraoxonase 1 and platelet activating factor acetylhydrolase.
2 hospholipase A(2) (Lp-PLA(2)), also known as platelet-activating factor acetylhydrolase.
3 ted protein and as one subunit of the enzyme platelet-activating factor acetylhydrolase.
4  encoding the alpha subunit of intracellular platelet-activating factor acetylhydrolase.
5 roteins such as alpha-N-catenin (CTNNA2) and platelet-activating factor acetylhydrolase 1b regulatory
6                                              Platelet-activating factor acetylhydrolase 1B1 (LIS1), a
7 eration by ectopic expression of PL-specific platelet-activating factor acetylhydrolase 2 (PAFAH2) ma
8     A recent report demonstrates that plasma platelet-activating factor acetylhydrolase activity incr
9 om allergy, such as suggesting that baseline platelet-activating factor acetylhydrolase activity leve
10                               Measurement of platelet-activating factor acetylhydrolase activity repr
11 ll dense low-density lipoproteins, increased platelet-activating factor acetylhydrolase activity, and
12 nts, the most potent effect was observed for platelet activating factor acetylhydrolase alpha (Paf-AH
13 coding complement component receptor 2/CD21, platelet-activating factor acetylhydrolase, and oxidized
14                                          The platelet-activating factor acetylhydrolases are enzymes
15                                       Plasma platelet-activating factor acetylhydrolase becomes progr
16 tions in the relative levels of paraoxonase, platelet-activating factor acetylhydrolase, ceruloplasmi
17 lesterolemic human plasma with a recombinant platelet-activating factor acetylhydrolase completely ab
18 izygous mutations in the human gene encoding platelet-activating factor acetylhydrolase IB subunit al
19            The activities of paraoxonase and platelet-activating factor acetylhydrolase in HDL decrea
20 imal study, transfection of tumor cells with platelet-activating factor acetylhydrolase inhibited tum
21 nt controversy over whether paraoxonase 1 or platelet-activating factor acetylhydrolase is responsibl
22 n-associated phospholipase A2, also known as platelet-activating factor acetylhydrolase, is a new ris
23 lation and elongation protein zeta-1 (FEZ1), platelet-activating factor acetylhydrolase, isoform Ib,
24 e inconclusive in determining whether plasma platelet-activating factor acetylhydrolase, or lipoprote
25 with the HDL-associated enzymes paraoxonase, platelet activating factor acetylhydrolase (PAF), and gl
26 gulation of expression of the plasma form of platelet-activating factor acetylhydrolase (PAF AH) in t
27                                              Platelet-activating factor acetylhydrolase (PAF-AH) acti
28                                              Platelet-activating factor acetylhydrolase (PAF-AH) is a
29                                   The enzyme platelet-activating factor acetylhydrolase (PAF-AH) rapi
30 or was inactivated by alkaline hydrolysis or platelet-activating factor acetylhydrolase (PAF-AH) trea
31 the possibility that the activity represents platelet-activating factor acetylhydrolase (PAF-AH), an
32           Normal rat bile contains secretory platelet-activating factor acetylhydrolase (PAF-AH), the
33                                              Platelet-activating factor acetylhydrolases (PAF-AHs) ar
34                                              Platelet-activating factor acetylhydrolases (PAF-AHs) pl
35  lycopene), and antioxidant enzyme activity (platelet-activating factor acetylhydrolase [PAF-AH] and
36                               We report that platelet-activating factor acetylhydrolase (PAFAH) Ib, c
37 t that the cytoplasmic PLA(2) enzyme complex platelet-activating factor acetylhydrolase (PAFAH) Ib, w
38 fective milk containing diminished levels of platelet-activating factor acetylhydrolase (PAFAH).
39 fied the gene encoding the alpha2 subunit of platelet-activating factor acetylhydrolase (Pafah1a2) at
40  mutation or deletion of the beta subunit of platelet-activating factor acetylhydrolase (PAFAH1B1, al
41 nzymes, BChE and a new extracellular form of platelet-activating factor acetylhydrolase, PAFAH1b2.
42                                              Platelet-activating factor acetylhydrolase (PLA2G7) is a
43 ated phospholipase A2 (Lp-PLA2), also called platelet-activating factor acetylhydrolase, plays in ath
44                                 Human plasma platelet activating factor acetylhydrolase (pPAF-AH) is
45                       Lp-PLA2, also known as platelet-activating factor acetylhydrolase, rapidly clea
46 kDa) phospholipase A(2) (cPLA(2)) and plasma platelet-activating factor acetylhydrolase (rPAF-AH).
47 rpose of this study was to determine whether platelet-activating factor acetylhydrolase Sse and strep
48 creened by enzymatic assays for SpeB and the platelet-activating factor acetylhydrolase Sse, and a ne
49                         Lis1 copurifies with platelet-activating factor acetylhydrolase subunits alph
50  of lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase), the express
51 ctive JRA is associated with lower levels of platelet activating factor acetylhydrolase, which may co